Article
Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility.
Pharmacotherapy - 1 Dec 2010
Scheetz Marc H, Knechtel Stephanie A, Postelnick Michael J, Malczynski Michael, Qi Chao
Abstract excerpt
STUDY OBJECTIVE: To evaluate the differences in clinical outcomes in patients with linezolid-intermediate or -resistant vancomycin-resistant enterococci (LIRVRE) isolates, as defined by the presence of the G2576T mutation, compared with patients who had linezolid-susceptible VRE (LSVRE) isolates in order to further discern the clinical relevance of linezolid resistance associated with this mutation. DESIGN:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
